Stephane Bancel serves as Executive at BG Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Stephane Bancel has executed 1571 insider transactions totaling $1.2B, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 11, 2025 involved exercising options for 688,073 shares valued at $7.5M.
Stephane Bancel currently holds 6,181,970 shares of BG Medicine, Inc. (BGMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephane Bancel has been a net seller of BGMD stock. They have purchased $226.2K and sold $1.2B worth of shares.
Stephane Bancel's most recent insider trade was on Dec 11, 2025, when they sold 688,073 shares at $10.90 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 16, 2024 | MRNA | $2.3M | Sale | 26,351 | $88.88 | Planned |
| Feb 14, 2024 | MRNA | $0 | Award | 56,736 | $N/A | Planned |
| Sep 15, 2023 | MRNA | $0 | Other | 17,893 | $N/A | Discretionary |
| Jun 28, 2023 | MRNA | $45.0K | Sale | 366 | $123.05 | Planned |
| Jun 28, 2023 | MRNA | $26.9K | Option Exercise | 27,155 | $0.99 | Planned |
| Jun 28, 2023 | MRNA | $274.2K | Sale | 2,278 | $120.39 | Planned |
| Jun 28, 2023 | MRNA | $1.4M | Sale | 11,417 | $121.40 | Planned |
| Jun 28, 2023 | MRNA | $1.6M | Sale | 13,094 | $122.01 | Planned |
| Jun 22, 2023 | MRNA | $1.8M | Sale | 15,171 | $119.87 | Planned |
| Jun 22, 2023 | MRNA | $3.0M | Sale | 24,829 | $119.13 | Planned |
| Jun 22, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Jun 21, 2023 | MRNA | $2.4M | Sale | 19,289 | $122.21 | Planned |
| Jun 21, 2023 | MRNA | $2.5M | Sale | 20,711 | $121.77 | Planned |
| Jun 21, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Jun 15, 2023 | MRNA | $1.9M | Sale | 14,277 | $129.77 | Planned |
| Jun 15, 2023 | MRNA | $918.7K | Sale | 7,115 | $129.12 | Planned |
| Jun 15, 2023 | MRNA | $1.1M | Sale | 8,443 | $127.99 | Planned |
| Jun 15, 2023 | MRNA | $682.9K | Sale | 5,377 | $127.01 | Planned |
| Jun 15, 2023 | MRNA | $601.4K | Sale | 4,788 | $125.61 | Planned |
| Jun 15, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Jun 14, 2023 | MRNA | $1.1M | Sale | 8,510 | $127.25 | Planned |
| Jun 14, 2023 | MRNA | $2.6M | Sale | 20,848 | $126.10 | Planned |
| Jun 14, 2023 | MRNA | $1.3M | Sale | 10,642 | $125.32 | Planned |
| Jun 14, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Jun 8, 2023 | MRNA | $2.7M | Sale | 22,215 | $123.58 | Planned |
| Jun 8, 2023 | MRNA | $2.2M | Sale | 17,396 | $124.53 | Planned |
| Jun 8, 2023 | MRNA | $48.7K | Sale | 389 | $125.22 | Planned |
| Jun 8, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |